{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,13]],"date-time":"2026-02-13T21:38:57Z","timestamp":1771018737252,"version":"3.50.1"},"reference-count":131,"publisher":"Bentham Science Publishers Ltd.","issue":"5","content-domain":{"domain":["eurekaselect.com"],"crossmark-restriction":true},"short-container-title":["CPB"],"published-print":{"date-parts":[[2022,4]]},"abstract":"<jats:sec>\n<jats:title>Abstract:<\/jats:title>\n<jats:p>Alzheimer's disease (AD) is a brain-linked pathophysiological condition with neuronal degeneration\nand cognition dysfunctions and other debilitations. Due to the growing prevalence of AD,\nthere is a highly commended trend to accelerate and develop analytical technologies for easy, costeffective,\nand sensitive detection of AD biomarkers. Biosensors are commanding analytical devices that\ncan conduct biological responses on transducers into measurable signals. This review focuses on up-todate\ndevelopmets, contests, and tendencies regarding AD biosensing principally, with the emphasis on\nthe exclusive possessions of nanomaterials. In the last decade, remarkable advancements have been\nachieved to the progression of biosensors, predominantly optical and electrochemical, for the detection\nof AD biomarkers. These analytical devices can assist the case finding and management of AD.<\/jats:p>\n<\/jats:sec>","DOI":"10.2174\/2666796702666210709122407","type":"journal-article","created":{"date-parts":[[2021,7,12]],"date-time":"2021-07-12T11:25:22Z","timestamp":1626089122000},"page":"634-644","update-policy":"https:\/\/doi.org\/10.2174\/bsp_crossmark_policy","source":"Crossref","is-referenced-by-count":12,"title":["A Concise Overview of Biosensing Technologies for the Detection of\nAlzheimer's Disease Biomarkers"],"prefix":"10.2174","volume":"23","author":[{"given":"Marjan","family":"Talebi","sequence":"first","affiliation":[{"name":"Department of Pharmacognosy and Pharmaceutical Biotechnology, School of Pharmacy, Shahid Beheshti University of\nMedical Sciences, Tehran, Iran"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hadi","family":"Esmaeeli","sequence":"additional","affiliation":[{"name":"Department of Research &amp; Development, Niak Pharmaceutical Co., Gorgan, Iran | Faculty of Pharmacy, Mazandaran University of Medical Sciences, Sari, Iran"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1951-8163","authenticated-orcid":true,"given":"Mohsen","family":"Talebi","sequence":"additional","affiliation":[{"name":"Department of Chemistry and Biochemistry,\nUniversity of Texas at Arlington, Arlington, TX, USA | Viatris Pharmaceuticals Inc., 3300 Research Plaza, San\nAntonio, Texas, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9579-8339","authenticated-orcid":true,"given":"Tahereh","family":"Farkhondeh","sequence":"additional","affiliation":[{"name":"Cardiovascular Diseases Research Center, Birjand University of Medical Sciences, Birjand,\nIran | Faculty of Pharmacy, Birjand University of Medical Sciences, Birjand, Iran"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5461-9579","authenticated-orcid":true,"given":"Saeed","family":"Samarghandian","sequence":"additional","affiliation":[{"name":"Noncommunicable Diseases Research\nCenter, Neyshabur University of Medical Sciences, Neyshabur, Iran"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"965","reference":[{"key":"ref=1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(15)01124-1","volume":"16","author":"Farkhondeh T.","year":"2018","unstructured":"Farkhondeh T.; Samarghandian S.; Shahri A.M.P.; Samini F.; The neuroprotective effects of thymoquinone: A review. Dose Response 2018,16(2)","journal-title":"Dose Response"},{"key":"ref=2","doi-asserted-by":"publisher","first-page":"387","DOI":"10.1016\/S0140-6736(06)69113-7","volume":"368","author":"Blennow K.","year":"2006","unstructured":"Blennow K.; de Leon M.J.; Zetterberg H.; Alzheimer\u2019s disease. Lancet 2006,368(9533),387-403","journal-title":"Lancet"},{"key":"ref=3","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1016\/j.snb.2008.09.006","volume":"139","author":"Hegnerov&#xE1; K.","year":"2009","unstructured":"Hegnerov&#xE1; K.; Bockov&#xE1; M.; Vaisocherov&#xE1; H.; Kri\u0161tofikov&#xE1; Z.; \u0158&#xED;&#x10D;n&#xFD; J.; \u0158&#xED;pov&#xE1; D.; Homola J.; Surface plasmon resonance biosensors for detection of Alzheimer disease biomarker. Sens Actuators B Chem 2009,139(1),69-73","journal-title":"Sens Actuators B Chem"},{"key":"ref=4","doi-asserted-by":"publisher","first-page":"367","DOI":"10.1016\/j.jalz.2018.02.001","volume":"14","year":"2018","unstructured":"2018 Alzheimer\u2019s disease facts and figures. Alzheimers Dement 2018,14(3),367-429","journal-title":"Alzheimers Dement"},{"key":"ref=5","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1007\/s40778-018-0123-y","volume":"4","author":"Shafiee A.","year":"2018","unstructured":"Shafiee A.; Ghadiri E.; Kassis J.; Pourhabibi Zarandi N.; Atala A.; Biosensing technologies for medical applications, manufacturing, and regenerative medicine. Curr Stem Cell Rep 2018,4(2),105-115","journal-title":"Curr Stem Cell Rep"},{"key":"ref=6","doi-asserted-by":"publisher","first-page":"164","DOI":"10.3389\/fnmol.2018.00164","volume":"11","author":"Abreu C.M.","year":"2018","unstructured":"Abreu C.M.; Soares-Dos-Reis R.; Melo P.N.; Relvas J.B.; Guimar&#xE3;es J.; S&#xE1; M.J.; Cruz A.P.; Mendes Pinto I.; Emerging biosensing technologies for neuroinflammatory and neurodegenerative disease diagnostics. Front Mol Neurosci 2018,11(164),164","journal-title":"Front Mol Neurosci"},{"key":"ref=7","doi-asserted-by":"publisher","DOI":"10.1016\/j.biopha.2021.111377","volume":"137","author":"Rai S.N.","year":"2021","unstructured":"Rai S.N.; Mishra D.; Singh P.; Vamanu E.; Singh M.P.; Therapeutic applications of mushrooms and their biomolecules along with a glimpse of in silico approach in neurodegenerative diseases. Biomed Pharmacother 2021,137","journal-title":"Biomed Pharmacother"},{"key":"ref=8","doi-asserted-by":"publisher","first-page":"664","DOI":"10.2174\/1570159X15666170823095628","volume":"16","author":"Makhouri F.R.","year":"2018","unstructured":"Makhouri F.R.; Ghasemi J.B.; In silico studies in drug research against neurodegenerative diseases. Curr Neuropharmacol 2018,16(6),664-725","journal-title":"Curr Neuropharmacol"},{"key":"ref=9","doi-asserted-by":"publisher","DOI":"10.3390\/molecules22091571","volume":"22","author":"Maruca A.","year":"2017","unstructured":"Maruca A.; Moraca F.; Rocca R.; Molisani F.; Alcaro F.; Gidaro M.C.; Alcaro S.; Costa G.; Ortuso F.; Chemoinformatic database building and in silico hit-identification of potential multi-targeting bioactive compounds extracted from mushroom species. Molecules 2017,22(9)","journal-title":"Molecules"},{"key":"ref=10","doi-asserted-by":"publisher","first-page":"1821","DOI":"10.1016\/S0140-6736(09)61829-8","volume":"374","author":"Sousa R.M.","year":"2009","unstructured":"Sousa R.M.; Ferri C.P.; Acosta D.; Albanese E.; Guerra M.; Huang Y.; Jacob K.S.; Jotheeswaran A.T.; Rodriguez J.J.L.; Pichardo G.R.; Rodriguez M.C.; Salas A.; Sosa A.L.; Williams J.; Zuniga T.; Prince M.; Contribution of chronic diseases to disability in elderly people in countries with low and middle incomes: A 10\/66 Dementia Research Group population-based survey. Lancet 2009,374(9704),1821-1830","journal-title":"Lancet"},{"key":"ref=11","author":"Talebi M.","year":"2020","unstructured":"Talebi M.; Mojab F.;  A systematic review of preclinical and clinical studies on therapeutic potential of piper nigrum on cognitive impairment in alzheimer\u2019s disease and other biological conditions of memory loss 2020","journal-title":"A systematic review of preclinical and clinical studies on therapeutic potential of piper nigrum on cognitive impairment in alzheimer\u2019s disease and other biological conditions of memory loss"},{"key":"ref=12","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1016\/j.jalz.2012.11.007","volume":"9","author":"Prince M.","year":"2013","unstructured":"Prince M.; Bryce R.; Albanese E.; Wimo A.; Ribeiro W.; Ferri C.P.; The global prevalence of dementia: A systematic review and metaanalysis. Alzheimers Dement 2013,9(1),63-75.e2","journal-title":"Alzheimers Dement"},{"key":"ref=13","doi-asserted-by":"publisher","first-page":"2112","DOI":"10.1016\/S0140-6736(05)67889-0","volume":"366","author":"Ferri C.P.","year":"2005","unstructured":"Ferri C.P.; Prince M.; Brayne C.; Brodaty H.; Fratiglioni L.; Ganguli M.; Hall K.; Hasegawa K.; Hendrie H.; Huang Y.; Jorm A.; Mathers C.; Menezes P.R.; Rimmer E.; Scazufca M.; Global prevalence of dementia: A Delphi consensus study. Lancet 2005,366(9503),2112-2117","journal-title":"Lancet"},{"key":"ref=14","doi-asserted-by":"publisher","first-page":"017","DOI":"10.1186\/s13195-017-0297-z","volume":"9","author":"Crous-Bou M.","year":"2017","unstructured":"Crous-Bou M.; Minguill&#xF3;n C.; Gramunt N.; Molinuevo J. L.;  Alzheimer's disease prevention: from risk factors to early interventionAlzheimers Res Ther, 2017,9(1),017-029","journal-title":"Alzheimer's disease prevention: from risk factors to early interventionAlzheimers Res Ther,"},{"key":"ref=15","doi-asserted-by":"publisher","first-page":"843","DOI":"10.2147\/IJN.S152163","volume":"13","author":"Sun L.","year":"2018","unstructured":"Sun L.; Zhong Y.; Gui J.; Wang X.; Zhuang X.; Weng J.; A hydrogel biosensor for high selective and sensitive detection of amyloid-beta oligomers. Int J Nanomedicine 2018,13,843-856","journal-title":"Int J Nanomedicine"},{"key":"ref=16","first-page":"185","volume":"15","author":"Faizi M.","year":"2016","unstructured":"Faizi M.; Seydi E.; Abarghuyi S.; Salimi A.; Nasoohi S.; Pourahmad J.; A search for mitochondrial damage in alzheimer\u2019s disease using isolated rat brain mitochondria. Iran J Pharm Res 2016,15(Suppl.),185-195","journal-title":"Iran J Pharm Res"},{"key":"ref=17","doi-asserted-by":"publisher","first-page":"1161","DOI":"10.12688\/f1000research.14506.1","volume":"7","author":"Weller J.","year":"2018","unstructured":"Weller J.; Budson A.; Current understanding of Alzheimer\u2019s disease diagnosis and treatment. F1000 Res 2018,7,1161","journal-title":"F1000 Res"},{"key":"ref=18","doi-asserted-by":"publisher","DOI":"10.1016\/j.biopha.2020.110590","volume":"130","author":"Talebi M.","year":"2020","unstructured":"Talebi M.; Talebi M.; Farkhondeh T.; Samarghandian S.; Molecular mechanism-based therapeutic properties of honey. Biomed Pharmacother 2020,130","journal-title":"Biomed Pharmacother"},{"key":"ref=19","volume":"11","author":"Talebi M.","year":"2021","unstructured":"Talebi M.; Talebi M.; Samarghandian S.;  Association of crocus sativus with cognitive dysfunctions and alzheimer\u2019s disease: A systematic reviewBiointerface Res Appl Chem 2021,11(1)","journal-title":"Association of crocus sativus with cognitive dysfunctions and alzheimer\u2019s disease: A systematic reviewBiointerface Res Appl Chem"},{"key":"ref=20","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1016\/j.ijbiomac.2021.01.042","volume":"172","author":"Talebi M.","year":"2021","unstructured":"Talebi M.; Talebi M.; Kakouri E.; Farkhondeh T.; Pourbagher-Shahri A.M.; Tarantilis P.A.; Samarghandian S.; Tantalizing role of p53 molecular pathways and its coherent medications in neurodegenerative diseases. Int J Biol Macromol 2021,172,93-103","journal-title":"Int J Biol Macromol"},{"key":"ref=21","doi-asserted-by":"publisher","first-page":"142","DOI":"10.1002\/brb3.41","volume":"2","author":"Faizi M.","year":"2012","unstructured":"Faizi M.; Bader P.L.; Saw N.; Nguyen T.V.; Beraki S.; Wyss-Coray T.; Longo F.M.; Shamloo M.; Thy1-hAPP(Lond\/Swe+) mouse model of Alzheimer\u2019s disease displays broad behavioral deficits in sensorimotor, cognitive and social function. Brain Behav 2012,2(2),142-154","journal-title":"Brain Behav"},{"key":"ref=22","doi-asserted-by":"publisher","first-page":"1447","DOI":"10.1136\/bmj.322.7300.1447","volume":"322","author":"Kivipelto M.","year":"2001","unstructured":"Kivipelto M.; Helkala E.L.; Laakso M.P.; H&#xE4;nninen T.; Hallikainen M.; Alhainen K.; Soininen H.; Tuomilehto J.; Nissinen A.; Midlife vascular risk factors and Alzheimer\u2019s disease in later life: Longitudinal, population based study. BMJ 2001,322(7300),1447-1451","journal-title":"BMJ"},{"key":"ref=23","doi-asserted-by":"publisher","DOI":"10.1016\/j.neuropharm.2013.07.004","author":"Anand R.","unstructured":"Anand R.; Gill K.D.; Mahdi A.A.;  Therapeutics of Alzheimer\u2019s\tdisease: Past, present and future Neuropharmacology, 2014, 76(Pt A), 27-50","journal-title":"Therapeutics of Alzheimer\u2019s\tdisease: Past, present and future Neuropharmacology, 2014, 76(Pt A), 27-50"},{"key":"ref=24","doi-asserted-by":"publisher","first-page":"883","DOI":"10.14336\/AD.2018.1030","volume":"10","author":"Fuellen G.","year":"2019","unstructured":"Fuellen G.; Jansen L.; Cohen A.A.; Luyten W.; Gogol M.; Simm A.; Saul N.; Cirulli F.; Berry A.; Antal P.; K&#xF6;hling R.; Wouters B.; M&#xF6;ller S.; Health and aging: Unifying concepts, scores, biomarkers and pathways. Aging Dis 2019,10(4),883-900","journal-title":"Aging Dis"},{"key":"ref=25","doi-asserted-by":"publisher","first-page":"182","DOI":"10.1602\/neurorx.1.2.182","volume":"1","author":"Mayeux R.","year":"2004","unstructured":"Mayeux R.; Biomarkers: potential uses and limitations. NeuroRx 2004,1(2),182-188","journal-title":"NeuroRx"},{"key":"ref=26","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.jalz.2011.10.007","volume":"8","author":"Hyman B.T.","year":"2012","unstructured":"Hyman B.T.; Phelps C.H.; Beach T.G.; Bigio E.H.; Cairns N.J.; Carrillo M.C.; Dickson D.W.; Duyckaerts C.; Frosch M.P.; Masliah E.; Mirra S.S.; Nelson P.T.; Schneider J.A.; Thal D.R.; Thies B.; Trojanowski J.Q.; Vinters H.V.; Montine T.J.; National institute on aging-alzheimer\u2019s association guidelines for the neuropathologic assessment of Alzheimer\u2019s disease. Alzheimers Dement 2012,8(1),1-13","journal-title":"Alzheimers Dement"},{"key":"ref=27","doi-asserted-by":"publisher","first-page":"740","DOI":"10.1016\/j.neuron.2014.01.045","volume":"81","author":"Kanekiyo T.","year":"2014","unstructured":"Kanekiyo T.; Xu H.; Bu G.; ApoE and A&#x3B2; in Alzheimer\u2019s disease: Accidental encounters or partners? Neuron 2014,81(4),740-754","journal-title":"Neuron"},{"key":"ref=28","doi-asserted-by":"publisher","first-page":"2814","DOI":"10.1093\/brain\/awv236","volume":"138","author":"Braak H.","year":"2015","unstructured":"Braak H.; Del Tredici K.; The preclinical phase of the pathological process underlying sporadic Alzheimer\u2019s disease. Brain 2015,138(Pt 10),2814-2833","journal-title":"Brain"},{"key":"ref=29","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1038\/nchembio.719","volume":"8","author":"Bieschke J.","year":"2011","unstructured":"Bieschke J.; Herbst M.; Wiglenda T.; Friedrich R.P.; Boeddrich A.; Schiele F.; Kleckers D.; Lopez del Amo J.M.; Gr&#xFC;ning B.A.; Wang Q.; Schmidt M.R.; Lurz R.; Anwyl R.; Schnoegl S.; F&#xE4;ndrich M.; Frank R.F.; Reif B.; G&#xFC;nther S.; Walsh D.M.; Wanker E.E.; Small-molecule conversion of toxic oligomers to nontoxic &#x3B2;-sheet-rich amyloid fibrils. Nat Chem Biol 2011,8(1),93-101","journal-title":"Nat Chem Biol"},{"key":"ref=30","doi-asserted-by":"publisher","first-page":"631","DOI":"10.1212\/WNL.42.3.631","volume":"42","author":"Arriagada P.V.","year":"1992","unstructured":"Arriagada P.V.; Growdon J.H.; Hedley-Whyte E.T.; Hyman B.T.; Neurofibrillary tangles but not senile plaques parallel duration and severity of Alzheimer\u2019s disease. Neurology 1992,42(3 Pt 1),631-639","journal-title":"Neurology"},{"key":"ref=31","doi-asserted-by":"publisher","DOI":"10.1016\/j.biopha.2020.111088","volume":"133","author":"Talebi M.","year":"2021","unstructured":"Talebi M.; \u0130lg&#xFC;n S.; Ebrahimi V.; Talebi M.; Farkhondeh T.; Ebrahimi H.; Samarghandian S.; Zingiber officinale ameliorates Alzheimer\u2019s disease and cognitive impairments: Lessons from preclinical studies. Biomed Pharmacother 2021,133","journal-title":"Biomed Pharmacother"},{"key":"ref=32","doi-asserted-by":"publisher","first-page":"640","DOI":"10.1016\/j.bcp.2013.12.024","volume":"88","author":"Reitz C.","year":"2014","unstructured":"Reitz C.; Mayeux R.; Alzheimer disease: epidemiology, diagnostic criteria, risk factors and biomarkers. Biochem Pharmacol 2014,88(4),640-651","journal-title":"Biochem Pharmacol"},{"key":"ref=33","doi-asserted-by":"publisher","first-page":"655","DOI":"10.1016\/S1474-4422(06)70501-4","volume":"5","author":"van Oijen M.","year":"2006","unstructured":"van Oijen M.; Hofman A.; Soares H.D.; Koudstaal P.J.; Breteler M.M.; Plasma Abeta(1-40) and Abeta(1-42) and the risk of dementia: a prospective case-cohort study. Lancet Neurol 2006,5(8),655-660","journal-title":"Lancet Neurol"},{"key":"ref=34","doi-asserted-by":"publisher","first-page":"72","DOI":"10.1186\/s12951-021-00814-7","volume":"19","author":"Karki H.P.","year":"2021","unstructured":"Karki H.P.; Jang Y.; Jung J.; Oh J.; Advances in the development paradigm of biosample-based biosensors for early ultrasensitive detection of alzheimer\u2019s disease. J Nanobiotechnology 2021,19(1),72","journal-title":"J Nanobiotechnology"},{"key":"ref=35","doi-asserted-by":"publisher","first-page":"639","DOI":"10.1038\/s41582-018-0079-7","volume":"14","author":"Hampel H.","year":"2018","unstructured":"Hampel H.; O\u2019Bryant S.E.; Molinuevo J.L.; Zetterberg H.; Masters C.L.; Lista S.; Kiddle S.J.; Batrla R.; Blennow K.; Blood-based biomarkers for Alzheimer disease: Mapping the road to the clinic. Nat Rev Neurol 2018,14(11),639-652","journal-title":"Nat Rev Neurol"},{"key":"ref=36","author":"Mayeux R.","unstructured":"Mayeux R.; Honig L. S.; Tang M.-X.; Manly J.; Stern Y.; Schupf N.; Mehta P. D.;  Plasma A&#x3B2;40 and A&#x3B2;42 and Alzheimer\u2019s diseaseRelation to age, mortality, and risk, 2003, 61(9), 1185-1190","journal-title":"Plasma A&#x3B2;40 and A&#x3B2;42 and Alzheimer\u2019s diseaseRelation to age, mortality, and risk, 2003, 61(9), 1185-1190"},{"key":"ref=37","doi-asserted-by":"publisher","first-page":"354","DOI":"10.1001\/archneur.64.3.354","volume":"64","author":"Graff-Radford N.R.","year":"2007","unstructured":"Graff-Radford N.R.; Crook J.E.; Lucas J.; Boeve B.F.; Knopman D.S.; Ivnik R.J.; Smith G.E.; Younkin L.H.; Petersen R.C.; Younkin S.G.; Association of low plasma Abeta42\/Abeta40 ratios with increased imminent risk for mild cognitive impairment and Alzheimer disease. Arch Neurol 2007,64(3),354-362","journal-title":"Arch Neurol"},{"key":"ref=38","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1186\/alzrt163","volume":"5","author":"Zetterberg H.","year":"2013","unstructured":"Zetterberg H.; Wilson D.; Andreasson U.; Minthon L.; Blennow K.; Randall J.; Hansson O.; Plasma tau levels in Alzheimer\u2019s disease. Alzheimers Res Ther 2013,5(2),9","journal-title":"Alzheimers Res Ther"},{"key":"ref=39","doi-asserted-by":"publisher","first-page":"1827","DOI":"10.1212\/WNL.0000000000003246","volume":"87","author":"Mattsson N.","year":"2016","unstructured":"Mattsson N.; Zetterberg H.; Janelidze S.; Insel P.S.; Andreasson U.; Stomrud E.; Palmqvist S.; Baker D.; Tan Hehir C.A.; Jeromin A.; Hanlon D.; Song L.; Shaw L.M.; Trojanowski J.Q.; Weiner M.W.; Hansson O.; Blennow K.; Plasma tau in Alzheimer disease. Neurology 2016,87(17),1827-1835","journal-title":"Neurology"},{"key":"ref=40","doi-asserted-by":"publisher","first-page":"960","DOI":"10.1136\/jnnp-2020-323487","volume":"91","author":"Benussi A.","year":"2020","unstructured":"Benussi A.; Karikari T.K.; Ashton N.; Gazzina S.; Premi E.; Benussi L.; Ghidoni R.; Rodriguez J.L.; Emer\u0161i&#x10D; A.; Simr&#xE9;n J.; Binetti G.; Fostinelli S.; Giunta M.; Gasparotti R.; Zetterberg H.; Blennow K.; Borroni B.; Diagnostic and prognostic value of serum NfL and p-Tau181 in frontotemporal lobar degeneration. J Neurol Neurosurg Psychiatry 2020,91(9),960-967","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"ref=41","doi-asserted-by":"publisher","first-page":"821","DOI":"10.1007\/s00401-018-1932-x","volume":"136","author":"Molinuevo J.L.","year":"2018","unstructured":"Molinuevo J.L.; Ayton S.; Batrla R.; Bednar M.M.; Bittner T.; Cummings J.; Fagan A.M.; Hampel H.; Mielke M.M.; Mikulskis A.; O\u2019Bryant S.; Scheltens P.; Sevigny J.; Shaw L.M.; Soares H.D.; Tong G.; Trojanowski J.Q.; Zetterberg H.; Blennow K.; Current state of Alzheimer\u2019s fluid biomarkers. Acta Neuropathol 2018,136(6),821-853","journal-title":"Acta Neuropathol"},{"key":"ref=42","doi-asserted-by":"publisher","DOI":"10.3390\/jpm10030085","volume":"10","author":"Zou K.","year":"2020","unstructured":"Zou K.; Abdullah M.; Michikawa M.; Current biomarkers for alzheimer\u2019s disease: From CSF to blood. J Pers Med 2020,10(3)","journal-title":"J Pers Med"},{"key":"ref=43","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1016\/j.exger.2009.10.010","volume":"45","author":"Hampel H.","year":"2010","unstructured":"Hampel H.; Blennow K.; Shaw L.M.; Hoessler Y.C.; Zetterberg H.; Trojanowski J.Q.; Total and phosphorylated tau protein as biological markers of Alzheimer\u2019s disease. Exp Gerontol 2010,45(1),30-40","journal-title":"Exp Gerontol"},{"key":"ref=44","doi-asserted-by":"publisher","first-page":"58","DOI":"10.1016\/j.jalz.2014.02.004","volume":"11","author":"Blennow K.","year":"2015","unstructured":"Blennow K.; Dubois B.; Fagan A.M.; Lewczuk P.; de Leon M.J.; Hampel H.; Clinical utility of cerebrospinal fluid biomarkers in the diagnosis of early Alzheimer\u2019s disease. Alzheimers Dement 2015,11(1),58-69","journal-title":"Alzheimers Dement"},{"key":"ref=45","doi-asserted-by":"publisher","first-page":"316","DOI":"10.1159\/000100926","volume":"23","author":"Hansson O.","year":"2007","unstructured":"Hansson O.; Zetterberg H.; Buchhave P.; Andreasson U.; Londos E.; Minthon L.; Blennow K.; Prediction of Alzheimer\u2019s disease using the CSF Abeta42\/Abeta40 ratio in patients with mild cognitive impairment. Dement Geriatr Cogn Disord 2007,23(5),316-320","journal-title":"Dement Geriatr Cogn Disord"},{"key":"ref=46","doi-asserted-by":"publisher","first-page":"1199","DOI":"10.3233\/JAD-170680","volume":"62","author":"Bjerke M.","year":"2018","unstructured":"Bjerke M.; Engelborghs S.; Cerebrospinal fluid biomarkers for early and differential Alzheimer\u2019s disease diagnosis. J Alzheimers Dis 2018,62(3),1199-1209","journal-title":"J Alzheimers Dis"},{"key":"ref=47","doi-asserted-by":"publisher","first-page":"1","DOI":"10.2174\/0929867327666201111141341","volume":"27","author":"Miku\u0142a E.","year":"2020","unstructured":"Miku\u0142a E.; Recent advancements in electrochemical biosensors for alzheimer\u2019s disease biomarkers detection. Curr Med Chem 2020,27,1-25","journal-title":"Curr Med Chem"},{"key":"ref=48","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1038\/nrneurol.2010.4","volume":"6","author":"Blennow K.","year":"2010","unstructured":"Blennow K.; Hampel H.; Weiner M.; Zetterberg H.; Cerebrospinal fluid and plasma biomarkers in Alzheimer disease. Nat Rev Neurol 2010,6(3),131-144","journal-title":"Nat Rev Neurol"},{"key":"ref=49","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1016\/j.nbd.2016.07.007","volume":"107","author":"Zenaro E.","year":"2017","unstructured":"Zenaro E.; Piacentino G.; Constantin G.; The blood-brain barrier in Alzheimer\u2019s disease. Neurobiol Dis 2017,107,41-56","journal-title":"Neurobiol Dis"},{"key":"ref=50","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1152\/physrev.00050.2017","volume":"99","author":"Sweeney M.D.","year":"2019","unstructured":"Sweeney M.D.; Zhao Z.; Montagne A.; Nelson A.R.; Zlokovic B.V.; Blood-Brain barrier: From physiology to disease and back. Physiol Rev 2019,99(1),21-78","journal-title":"Physiol Rev"},{"key":"ref=51","doi-asserted-by":"publisher","first-page":"a020412","DOI":"10.1101\/cshperspect.a020412","volume":"7","author":"Daneman R.","year":"2015","unstructured":"Daneman R.; Prat A.; The blood-brain barrier. Cold Spring Harb Perspect Biol 2015,7(1),a020412-a020412","journal-title":"Cold Spring Harb Perspect Biol"},{"key":"ref=52","doi-asserted-by":"publisher","first-page":"385","DOI":"10.3109\/00365517709091496","volume":"37","author":"Tibbling G.","year":"1977","unstructured":"Tibbling G.; Link H.; Ohman S.; Principles of albumin and IgG analyses in neurological disorders. I. Establishment of reference values. Scand J Clin Lab Invest 1977,37(5),385-390","journal-title":"Scand J Clin Lab Invest"},{"key":"ref=53","doi-asserted-by":"publisher","first-page":"897","DOI":"10.1136\/jnnp.57.8.897","volume":"57","author":"Andersson M.","year":"1994","unstructured":"Andersson M.; Alvarez-Cerme&#xF1;o J.; Bernardi G.; Cogato I.; Fredman P.; Frederiksen J.; Fredrikson S.; Gallo P.; Grimaldi L.M.; Gr&#xF8;nning M.; Cerebrospinal fluid in the diagnosis of multiple sclerosis: a consensus report. J Neurol Neurosurg Psychiatry 1994,57(8),897-902","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"ref=54","doi-asserted-by":"publisher","first-page":"1253","DOI":"10.1016\/j.neurobiolaging.2011.02.022","volume":"33","author":"de Souza L.C.","year":"2012","unstructured":"de Souza L.C.; Chupin M.; Lamari F.; Jardel C.; Leclercq D.; Colliot O.; Leh&#xE9;ricy S.; Dubois B.; Sarazin M.; CSF tau markers are correlated with hippocampal volume in Alzheimer\u2019s disease. Neurobiol Aging 2012,33(7),1253-1257","journal-title":"Neurobiol Aging"},{"key":"ref=55","doi-asserted-by":"publisher","first-page":"382","DOI":"10.1001\/archneurol.2008.596","volume":"66","author":"Tapiola T.","year":"2009","unstructured":"Tapiola T.; Alafuzoff I.; Herukka S.K.; Parkkinen L.; Hartikainen P.; Soininen H.; Pirttil&#xE4; T.; Cerebrospinal fluid beta-amyloid 42 and tau proteins as biomarkers of Alzheimer-type pathologic changes in the brain. Arch Neurol 2009,66(3),382-389","journal-title":"Arch Neurol"},{"key":"ref=56","doi-asserted-by":"publisher","first-page":"1600","DOI":"10.1212\/01.wnl.0000242732.06714.0f","volume":"67","author":"Ost M.","year":"2006","unstructured":"Ost M.; Nyl&#xE9;n K.; Csajbok L.; Ohrfelt A.O.; Tullberg M.; Wikkels&#xF6; C.; Nellg&#xE5;rd P.; Rosengren L.; Blennow K.; Nellg&#xE5;rd B.; Initial CSF total tau correlates with 1-year outcome in patients with traumatic brain injury. Neurology 2006,67(9),1600-1604","journal-title":"Neurology"},{"key":"ref=57","doi-asserted-by":"publisher","first-page":"S116","DOI":"10.4103\/0972-2327.74256","volume":"13","author":"Wattamwar P.R.","year":"2010","unstructured":"Wattamwar P.R.; Mathuranath P.S.; An overview of biomarkers in Alzheimer\u2019s disease. Ann Indian Acad Neurol 2010,13(Suppl. 2),S116-S123","journal-title":"Ann Indian Acad Neurol"},{"key":"ref=58","doi-asserted-by":"publisher","first-page":"643","DOI":"10.1111\/joim.12816","volume":"284","author":"Blennow K.","year":"2018","unstructured":"Blennow K.; Zetterberg H.; Biomarkers for Alzheimer\u2019s disease: Current status and prospects for the future. J Intern Med 2018,284(6),643-663","journal-title":"J Intern Med"},{"key":"ref=59","doi-asserted-by":"publisher","DOI":"10.4061\/2010\/606802","volume":"2010","author":"Anoop A.","year":"2010","unstructured":"Anoop A.; Singh P.K.; Jacob R.S.; Maji S.K.; CSF Biomarkers for Alzheimer\u2019s disease Diagnosis. Int J Alzheimers Dis 2010,2010","journal-title":"Int J Alzheimers Dis"},{"key":"ref=60","doi-asserted-by":"publisher","DOI":"10.1016\/j.talanta.2019.120644","volume":"210","author":"Brazaca L.C.","year":"2020","unstructured":"Brazaca L.C.; Sampaio I.; Zucolotto V.; Janegitz B.C.; Applications of biosensors in Alzheimer\u2019s disease diagnosis. Talanta 2020,210","journal-title":"Talanta"},{"key":"ref=61","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1016\/j.biochi.2017.12.015","volume":"147","author":"Shui B.","year":"2018","unstructured":"Shui B.; Tao D.; Florea A.; Cheng J.; Zhao Q.; Gu Y.; Li W.; Jaffrezic-Renault N.; Mei Y.; Guo Z.; Biosensors for Alzheimer\u2019s disease biomarker detection: A review. Biochimie 2018,147,13-24","journal-title":"Biochimie"},{"key":"ref=62","doi-asserted-by":"publisher","first-page":"828","DOI":"10.1016\/S0140-6736(13)60630-3","volume":"383","author":"Loy C.T.","year":"2014","unstructured":"Loy C.T.; Schofield P.R.; Turner A.M.; Kwok J.B.; Genetics of dementia. Lancet 2014,383(9919),828-840","journal-title":"Lancet"},{"key":"ref=63","doi-asserted-by":"publisher","DOI":"10.1016\/j.pnpbp.2020.110039","volume":"104","author":"\u0141uc M.","year":"2021","unstructured":"\u0141uc M.; Misiak B.; Paw\u0142owski M.; Sta\u0144czykiewicz B.; Zab\u0142ocka A.; Szcze&#x15B;niak D.; Pa\u0142\u0119ga A.; Rymaszewska J.; Gut microbiota in dementia. Critical review of novel findings and their potential application. Prog Neuropsychopharmacol Biol Psychiatry 2021,104","journal-title":"Prog Neuropsychopharmacol Biol Psychiatry"},{"key":"ref=64","doi-asserted-by":"publisher","first-page":"625","DOI":"10.1080\/14737175.2021.1923479","volume":"21","author":"Talebi M.","year":"2021","unstructured":"Talebi M.; Kakouri E.; Talebi M.; Tarantilis P.A.; Farkhondeh T.; \u0130lg&#xFC;n S.; Pourbagher-Shahri A.M.; Samarghandian S.; Nutraceuticals-based therapeutic approach: Recent advances to combat pathogenesis of Alzheimer\u2019s disease. Expert Rev Neurother 2021,21(6),625-642","journal-title":"Expert Rev Neurother"},{"key":"ref=65","doi-asserted-by":"publisher","first-page":"232","DOI":"10.1016\/j.jalz.2018.08.012","volume":"15","author":"Nho K.","year":"2019","unstructured":"Nho K.; Kueider-Paisley A.; MahmoudianDehkordi, S.; Arnold, M.; Risacher, S.L.; Louie, G.; Blach, C.; Baillie, R.; Han, X.; Kastenm&#xFC;ller, G.; Jia, W.; Xie, G.; Ahmad, S.; Hankemeier, T.; van Duijn, C.M.; Trojanowski, J.Q.; Shaw, L.M.; Weiner, M.W.; Doraiswamy, P.M.; Saykin, A.J.; Kaddurah-Daouk, R. Altered bile acid profile in mild cognitive impairment and Alzheimer\u2019s disease: Relationship to neuroimaging and CSF biomarkers. Alzheimers Dement 2019,15(2),232-244","journal-title":"Alzheimers Dement"},{"key":"ref=66","doi-asserted-by":"publisher","first-page":"1337","DOI":"10.3233\/JAD-180176","volume":"63","author":"Zhuang Z.Q.","year":"2018","unstructured":"Zhuang Z.Q.; Shen L.L.; Li W.W.; Fu X.; Zeng F.; Gui L.; L&#xFC; Y.; Cai M.; Zhu C.; Tan Y.L.; Zheng P.; Li H.Y.; Zhu J.; Zhou H.D.; Bu X.L.; Wang Y.J.; Gut microbiota is altered in patients with Alzheimer\u2019s disease. J Alzheimers Dis 2018,63(4),1337-1346","journal-title":"J Alzheimers Dis"},{"key":"ref=67","author":"Talebi M.","year":"2021","unstructured":"Talebi M.; Ebrahimi V.; Rasouli A.; Razi Soofiyani S.; Soleimanian A.; Tarhriz V.; A new insight on feasibility of pro\/pre\/synbiotics-based therapies in Alzheimer\u2019s disease. Probiotics Antimicrob Proteins 2021","journal-title":"Probiotics Antimicrob Proteins"},{"key":"ref=68","doi-asserted-by":"publisher","first-page":"60","DOI":"10.1016\/j.neurobiolaging.2016.08.019","volume":"49","author":"Cattaneo A.","year":"2017","unstructured":"Cattaneo A.; Cattane N.; Galluzzi S.; Provasi S.; Lopizzo N.; Festari C.; Ferrari C.; Guerra U.P.; Paghera B.; Muscio C.; Bianchetti A.; Volta G.D.; Turla M.; Cotelli M.S.; Gennuso M.; Prelle A.; Zanetti O.; Lussignoli G.; Mirabile D.; Bellandi D.; Gentile S.; Belotti G.; Villani D.; Harach T.; Bolmont T.; Padovani A.; Boccardi M.; Frisoni G.B.; Association of brain amyloidosis with pro-inflammatory gut bacterial taxa and peripheral inflammation markers in cognitively impaired elderly. Neurobiol Aging 2017,49,60-68","journal-title":"Neurobiol Aging"},{"key":"ref=69","doi-asserted-by":"publisher","first-page":"2786","DOI":"10.1093\/jn\/135.12.2786","volume":"135","author":"Clavel T.","year":"2005","unstructured":"Clavel T.; Fallani M.; Lepage P.; Levenez F.; Mathey J.; Rochet V.; S&#xE9;r&#xE9;zat M.; Sutren M.; Henderson G.; Bennetau-Pelissero C.; Tondu F.; Blaut M.; Dor&#xE9; J.; Coxam V.; Isoflavones and functional foods alter the dominant intestinal microbiota in postmenopausal women. J Nutr 2005,135(12),2786-2792","journal-title":"J Nutr"},{"key":"ref=70","doi-asserted-by":"publisher","first-page":"5330","DOI":"10.1021\/jf501546a","volume":"62","author":"Cuervo A.","year":"2014","unstructured":"Cuervo A.; Vald&#xE9;s L.; Salazar N.; de los Reyes-Gavil&#xE1;n C.G.; Ruas-Madiedo P.; Gueimonde M.; Gonz&#xE1;lez S.; Pilot study of diet and microbiota: interactive associations of fibers and polyphenols with human intestinal bacteria. J Agric Food Chem 2014,62(23),5330-5336","journal-title":"J Agric Food Chem"},{"key":"ref=71","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3390\/antiox4010001","volume":"4","author":"Due&#xF1;as M.","year":"2015","unstructured":"Due&#xF1;as M.; Cueva C.; Mu&#xF1;oz-Gonz&#xE1;lez I.; Jim&#xE9;nez-Gir&#xF3;n A.; S&#xE1;nchez-Pat&#xE1;n F.; Santos-Buelga C.; Moreno-Arribas M.V.; Bartolom&#xE9; B.; Studies on modulation of gut microbiota by wine polyphenols: From isolated cultures to omic approaches. Antioxidants 2015,4(1),1-21","journal-title":"Antioxidants"},{"key":"ref=72","doi-asserted-by":"publisher","first-page":"510","DOI":"10.1016\/j.anaerobe.2010.03.005","volume":"16","author":"Shinohara K.","year":"2010","unstructured":"Shinohara K.; Ohashi Y.; Kawasumi K.; Terada A.; Fujisawa T.; Effect of apple intake on fecal microbiota and metabolites in humans. Anaerobe 2010,16(5),510-515","journal-title":"Anaerobe"},{"key":"ref=73","doi-asserted-by":"publisher","first-page":"62","DOI":"10.3945\/ajcn.110.000075","volume":"93","author":"Tzounis X.","year":"2011","unstructured":"Tzounis X.; Rodriguez-Mateos A.; Vulevic J.; Gibson G.R.; Kwik-Uribe C.; Spencer J.P.; Prebiotic evaluation of cocoa-derived flavanols in healthy humans by using a randomized, controlled, double-blind, crossover intervention study. Am J Clin Nutr 2011,93(1),62-72","journal-title":"Am J Clin Nutr"},{"key":"ref=74","doi-asserted-by":"publisher","first-page":"607","DOI":"10.3390\/nu10050607","volume":"10","author":"Vamanu E.","year":"2018","unstructured":"Vamanu E.; Ene M.; Bi&#x21B;\u0103 B.; Ionescu C.; Cr\u0103ciun L.; S&#xE2;rbu I.; In vitro human microbiota response to exposure to silver nanoparticles biosynthesized with mushroom extract. Nutrients 2018,10(5),607","journal-title":"Nutrients"},{"key":"ref=75","doi-asserted-by":"publisher","first-page":"439","DOI":"10.3233\/JAD-2012-120082","volume":"31","author":"Wang L-S.","year":"2012","unstructured":"Wang L-S.; Leung Y.Y.; Chang S-K.; Leight S.; Knapik-Czajka M.; Baek Y.; Shaw L.M.; Lee V.M.Y.; Trojanowski J.Q.; Clark C.M.; Comparison of xMAP and ELISA assays for detecting cerebrospinal fluid biomarkers of Alzheimer\u2019s disease. J Alzheimers Dis 2012,31(2),439-445","journal-title":"J Alzheimers Dis"},{"key":"ref=76","doi-asserted-by":"publisher","first-page":"1215","DOI":"10.1001\/archneur.56.10.1215","volume":"56","author":"DeBiasi R.L.","year":"1999","unstructured":"DeBiasi R.L.; Tyler K.L.; Polymerase chain reaction in the diagnosis and management of central nervous system infections. Arch Neurol 1999,56(10),1215-1219","journal-title":"Arch Neurol"},{"key":"ref=77","doi-asserted-by":"publisher","first-page":"242","DOI":"10.4103\/1673-5374.244784","volume":"14","author":"Martinez B.","year":"2019","unstructured":"Martinez B.; Peplow P.V.; MicroRNAs as diagnostic and therapeutic tools for Alzheimer\u2019s disease: Advances and limitations. Neural Regen Res 2019,14(2),242-255","journal-title":"Neural Regen Res"},{"key":"ref=78","doi-asserted-by":"publisher","first-page":"549","DOI":"10.1586\/14789450.2014.939635","volume":"11","author":"Ghosh R.","year":"2014","unstructured":"Ghosh R.; Gilda J.E.; Gomes A.V.; The necessity of and strategies for improving confidence in the accuracy of western blots. Expert Rev Proteomics 2014,11(5),549-560","journal-title":"Expert Rev Proteomics"},{"key":"ref=79","doi-asserted-by":"publisher","first-page":"1158","DOI":"10.3389\/fneur.2018.01158","volume":"9","author":"Yao F.","year":"2019","unstructured":"Yao F.; Zhang K.; Zhang Y.; Guo Y.; Li A.; Xiao S.; Liu Q.; Shen L.; Ni J.; Identification of blood biomarkers for alzheimer\u2019s disease through computational prediction and experimental validation. Front Neurol 2019,9,1158-1158","journal-title":"Front Neurol"},{"key":"ref=80","doi-asserted-by":"publisher","first-page":"4811","DOI":"10.3390\/s130404811","volume":"13","author":"Putzbach W.","year":"2013","unstructured":"Putzbach W.; Ronkainen N.J.; Immobilization techniques in the fabrication of nanomaterial-based electrochemical biosensors: A review. Sensors (Basel) 2013,13(4),4811-4840","journal-title":"Sensors (Basel)"},{"key":"ref=81","doi-asserted-by":"publisher","first-page":"293","DOI":"10.1016\/j.nbd.2009.07.021","volume":"36","author":"Shankar G.M.","year":"2009","unstructured":"Shankar G.M.; Leissring M.A.; Adame A.; Sun X.; Spooner E.; Masliah E.; Selkoe D.J.; Lemere C.A.; Walsh D.M.; Biochemical and immunohistochemical analysis of an Alzheimer\u2019s disease mouse model reveals the presence of multiple cerebral Abeta assembly forms throughout life. Neurobiol Dis 2009,36(2),293-302","journal-title":"Neurobiol Dis"},{"key":"ref=82","doi-asserted-by":"publisher","first-page":"7865","DOI":"10.3390\/ijms15057865","volume":"15","author":"Liu Y.","year":"2014","unstructured":"Liu Y.; Qing H.; Deng Y.; Biomarkers in Alzheimer\u2019s disease analysis by mass spectrometry-based proteomics. Int J Mol Sci 2014,15(5),7865-7882","journal-title":"Int J Mol Sci"},{"key":"ref=83","doi-asserted-by":"publisher","first-page":"1151","DOI":"10.2217\/bmm.14.42","volume":"8","author":"Kehoe E.G.","year":"2014","unstructured":"Kehoe E.G.; McNulty J.P.; Mullins P.G.; Bokde A.L.; Advances in MRI biomarkers for the diagnosis of Alzheimer\u2019s disease. Biomarkers Med 2014,8(9),1151-1169","journal-title":"Biomarkers Med"},{"key":"ref=84","doi-asserted-by":"publisher","first-page":"a006213","DOI":"10.1101\/cshperspect.a006213","volume":"2","author":"Johnson K.A.","year":"2012","unstructured":"Johnson K.A.; Fox N.C.; Sperling R.A.; Klunk W.E.; Brain imaging in Alzheimer disease. Cold Spring Harb Perspect Med 2012,2(4),a006213-a006213","journal-title":"Cold Spring Harb Perspect Med"},{"key":"ref=85","volume":"7","author":"Sarin H.","year":"2015","unstructured":"Sarin H.;  Magnetic resonance imageable macromolecular probes for the diagnosis of solid malignancies and inflammatory disease statesProc 9th Indo Global Summit on Cancer Therapy 51. J Cancer Sci Ther2015,7(Suppl (10))","journal-title":"Magnetic resonance imageable macromolecular probes for the diagnosis of solid malignancies and inflammatory disease statesProc 9th Indo Global Summit on Cancer Therapy"},{"key":"ref=86","doi-asserted-by":"publisher","first-page":"627","DOI":"10.3233\/JAD-2011-110458","volume":"26","author":"Bloudek L.M.","year":"2011","unstructured":"Bloudek L.M.; Spackman D.E.; Blankenburg M.; Sullivan S.D.; Review and meta-analysis of biomarkers and diagnostic imaging in Alzheimer\u2019s disease. J Alzheimers Dis 2011,26(4),627-645","journal-title":"J Alzheimers Dis"},{"key":"ref=87","doi-asserted-by":"publisher","first-page":"e413","DOI":"10.1097\/RLU.0000000000000547","volume":"39","author":"Marcus C.","year":"2014","unstructured":"Marcus C.; Mena E.; Subramaniam R.M.; Brain PET in the diagnosis of Alzheimer\u2019s disease. Clin Nucl Med 2014,39(10),e413-e422","journal-title":"Clin Nucl Med"},{"key":"ref=88","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1042\/EBC20150001","volume":"60","author":"Bhalla N.","year":"2016","unstructured":"Bhalla N.; Jolly P.; Formisano N.; Estrela P.; Introduction to biosensors. Essays Biochem 2016,60(1),1-8","journal-title":"Essays Biochem"},{"key":"ref=89","doi-asserted-by":"publisher","first-page":"1663","DOI":"10.3390\/nano9121663","volume":"9","author":"Carneiro P.","year":"2019","unstructured":"Carneiro P.; Morais S.; Pereira M.C.; Nanomaterials towards biosensing of Alzheimer\u2019s disease biomarkers. Nanomaterials (Basel) 2019,9(12),1663","journal-title":"Nanomaterials (Basel)"},{"key":"ref=90","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1042\/EBC20150010","volume":"60","author":"Damborsk&#xFD; P.","year":"2016","unstructured":"Damborsk&#xFD; P.; \u0160vitel J.; Katrl&#xED;k, J. Optical biosensors. Essays Biochem 2016,60(1),91-100","journal-title":"Essays Biochem"},{"key":"ref=91","doi-asserted-by":"publisher","first-page":"5151","DOI":"10.1039\/C3AN00490B","volume":"138","author":"Qie Z.","year":"2013","unstructured":"Qie Z.; Ning B.; Liu M.; Bai J.; Peng Y.; Song N.; Lv Z.; Wang Y.; Sun S.; Su X.; Zhang Y.; Gao Z.; Fast detection of atrazine in corn using thermometric biosensors. Analyst (Lond) 2013,138(17),5151-5156","journal-title":"Analyst (Lond)"},{"key":"ref=92","doi-asserted-by":"publisher","first-page":"29","DOI":"10.3390\/bios8020029","volume":"8","author":"Hernandez-Vargas G.","year":"2018","unstructured":"Hernandez-Vargas G.; Sosa-Hern&#xE1;ndez J.E.; Saldarriaga-Hernandez S.; Villalba-Rodr&#xED;guez A.M.; Parra-Saldivar R.; Iqbal H.M.N.; Electrochemical biosensors: A solution to pollution detection with reference to environmental contaminants. Biosensors (Basel) 2018,8(2),29","journal-title":"Biosensors (Basel)"},{"key":"ref=93","first-page":"178","author":"Pohanka M.","year":"2017","unstructured":"Pohanka M.; Piezoelectric biosensor for the determination of tumor necrosis factor alpha. Talanta 2017,178","journal-title":"Talanta"},{"key":"ref=94","doi-asserted-by":"publisher","first-page":"1100","DOI":"10.1016\/j.ijbiomac.2020.06.239","volume":"162","author":"Ameri M.","year":"2020","unstructured":"Ameri M.; Shabaninejad Z.; Movahedpour A.; Sahebkar A.; Mohammadi S.; Hosseindoost S.; Ebrahimi M.S.; Savardashtaki A.; Karimipour M.; Mirzaei H.; Biosensors for detection of Tau protein as an Alzheimer\u2019s disease marker. Int J Biol Macromol 2020,162,1100-1108","journal-title":"Int J Biol Macromol"},{"key":"ref=95","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1016\/j.jobcr.2015.12.002","volume":"6","author":"Mehrotra P.","year":"2016","unstructured":"Mehrotra P.; Biosensors and their applications \u2013 A review. J Oral Biol Craniofac Res 2016,6(2),153-159","journal-title":"J Oral Biol Craniofac Res"},{"key":"ref=96","doi-asserted-by":"publisher","first-page":"1033","DOI":"10.3390\/s90201033","volume":"9","author":"Zhang X.","year":"2009","unstructured":"Zhang X.; Guo Q.; Cui D.; Recent advances in nanotechnology applied to biosensors. Sensors (Basel) 2009,9(2),1033-1053","journal-title":"Sensors (Basel)"},{"key":"ref=97","doi-asserted-by":"publisher","first-page":"291","DOI":"10.1002\/wnan.84","volume":"2","author":"Haun J.B.","year":"2010","unstructured":"Haun J.B.; Yoon T.J.; Lee H.; Weissleder R.; Magnetic nanoparticle biosensors. Wiley Interdiscip Rev Nanomed Nanobiotechnol 2010,2(3),291-304","journal-title":"Wiley Interdiscip Rev Nanomed Nanobiotechnol"},{"key":"ref=98","doi-asserted-by":"publisher","first-page":"6173","DOI":"10.1039\/C8TB01869C","volume":"6","author":"Ma F.","year":"2018","unstructured":"Ma F.; Li C.C.; Zhang C.Y.; Development of quantum dot-based biosensors: Principles and applications. J Mater Chem B Mater Biol Med 2018,6(39),6173-6190","journal-title":"J Mater Chem B Mater Biol Med"},{"key":"ref=99","doi-asserted-by":"crossref","first-page":"63","DOI":"10.3389\/fchem.2014.00063","volume":"2","author":"Holzinger M.","year":"2014","unstructured":"Holzinger M.; Le Goff A.; Cosnier S.; Nanomaterials for biosensing applications: A review. Front Chem 2014,2(63),63","journal-title":"Front Chem"},{"key":"ref=100","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1007\/BF03214964","volume":"43","author":"Li Y.","year":"2010","unstructured":"Li Y.; Schluesener H.J.; Xu S.; Gold nanoparticle-based biosensors. Gold Bull 2010,43(1),29-41","journal-title":"Gold Bull"},{"key":"ref=101","first-page":"59","volume":"3","author":"T&#xEE;lmaciu C-M.","year":"2015","unstructured":"T&#xEE;lmaciu C-M.; Morris M.C.; Carbon nanotube biosensors. Front Chem 2015,3(59),59","journal-title":"Front Chem"},{"key":"ref=102","doi-asserted-by":"publisher","first-page":"275","DOI":"10.1016\/j.addr.2016.06.001","volume":"105","author":"Lee J.","year":"2016","unstructured":"Lee J.; Kim J.; Kim S.; Min D-H.;  Biosensors based on graphene oxide and its biomedical applicationAdv Drug Deliv Rev, 2016,105((Pt B)),275-287","journal-title":"Biosensors based on graphene oxide and its biomedical applicationAdv Drug Deliv Rev,"},{"key":"ref=103","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1080\/20550324.2018.1478765","volume":"4","author":"Sireesha M.","year":"2018","unstructured":"Sireesha M.; Jagadeesh Babu V.; Kranthi Kiran A.S.; Ramakrishna S.; A review on carbon nanotubes in biosensor devices and their applications in medicine. Nanocomposites 2018,4(2),36-57","journal-title":"Nanocomposites"},{"key":"ref=104","doi-asserted-by":"publisher","first-page":"323","DOI":"10.1111\/j.1600-0404.1990.tb01563.x","volume":"81","author":"Blennow K.","year":"1990","unstructured":"Blennow K.; Wallin A.; Fredman P.; Karlsson I.; Gottfries C.G.; Svennerholm L.; Blood-brain barrier disturbance in patients with Alzheimer\u2019s disease is related to vascular factors. Acta Neurol Scand 1990,81(4),323-326","journal-title":"Acta Neurol Scand"},{"key":"ref=105","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1016\/0924-977X(90)90017-5","volume":"1","author":"Blennow K.","year":"1990","unstructured":"Blennow K.; Wallin A.; Fredman P.; Gottfries C.G.; Karlsson I.; Svennerholm L.; Intrathecal synthesis of immunoglobulins in patients with Alzheimer\u2019s disease. Eur Neuropsychopharmacol 1990,1(1),79-81","journal-title":"Eur Neuropsychopharmacol"},{"key":"ref=106","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1602\/neurorx.1.2.213","volume":"1","author":"Blennow K.","year":"2004","unstructured":"Blennow K.; Cerebrospinal fluid protein biomarkers for Alzheimer\u2019s disease. NeuroRx 2004,1(2),213-225","journal-title":"NeuroRx"},{"key":"ref=107","doi-asserted-by":"publisher","first-page":"605","DOI":"10.1016\/S1474-4422(03)00530-1","volume":"2","author":"Blennow K.","year":"2003","unstructured":"Blennow K.; Hampel H.; CSF markers for incipient Alzheimer\u2019s disease. Lancet Neurol 2003,2(10),605-613","journal-title":"Lancet Neurol"},{"key":"ref=108","doi-asserted-by":"publisher","first-page":"6115","DOI":"10.1039\/C6AY01910B","volume":"8","author":"Kaushik A.","year":"2016","unstructured":"Kaushik A.; Shah P.; Vabbina P.K.; Jayant R.D.; Tiwari S.; Vashist A.; Yndart A.; Nair M.; A label-free electrochemical immunosensor for beta-amyloid detection. Anal Methods 2016,8(31),6115-6120","journal-title":"Anal Methods"},{"key":"ref=109","doi-asserted-by":"publisher","first-page":"748","DOI":"10.1002\/elan.201600467","volume":"29","author":"El-Said W.A.","year":"2017","unstructured":"El-Said W.A.; Abd El-Hameed K.; Abo El-Maali N.; Sayyed H.G.; Label-free electrochemical sensor for ex-vivo monitoring of alzheimer\u2019s disease biomarker. Electroanalysis 2017,29(3),748-755","journal-title":"Electroanalysis"},{"key":"ref=110","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1016\/j.aca.2015.08.036","volume":"892","author":"Lien T.T.N.","year":"2015","unstructured":"Lien T.T.N.; Takamura Y.; Tamiya E.; Vestergaard M.C.; Modified screen printed electrode for development of a highly sensitive label-free impedimetric immunosensor to detect amyloid beta peptides. Anal Chim Acta 2015,892,69-76","journal-title":"Anal Chim Acta"},{"key":"ref=111","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0098992","volume":"9","author":"Lee Y.K.","year":"2014","unstructured":"Lee Y.K.; Lee K-S.; Kim W.M.; Sohn Y-S.; Detection of amyloid-&#x3B2;42 using a waveguide-coupled bimetallic surface plasmon resonance sensor chip in the intensity measurement mode. PLoS One 2014,9(6)","journal-title":"PLoS One"},{"key":"ref=112","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1016\/j.bios.2015.05.017","volume":"72","author":"Kang M.K.","year":"2015","unstructured":"Kang M.K.; Lee J.; Nguyen A.H.; Sim S.J.; Label-free detection of ApoE4-mediated &#x3B2;-amyloid aggregation on single nanoparticle uncovering Alzheimer\u2019s disease. Biosens Bioelectron 2015,72,197-204","journal-title":"Biosens Bioelectron"},{"key":"ref=113","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1016\/j.cattod.2017.02.039","volume":"295","author":"Diba F.S.","year":"2017","unstructured":"Diba F.S.; Kim S.; Lee H.J.; Electrochemical immunoassay for amyloid-beta 1\u201342 peptide in biological fluids interfacing with a gold nanoparticle modified carbon surface. Catal Today 2017,295,41-47","journal-title":"Catal Today"},{"key":"ref=114","doi-asserted-by":"publisher","first-page":"345","DOI":"10.1016\/j.bios.2013.07.004","volume":"50","author":"Oh J.","year":"2013","unstructured":"Oh J.; Yoo G.; Chang Y.W.; Kim H.J.; Jose J.; Kim E.; Pyun J.C.; Yoo K.H.; A carbon nanotube metal semiconductor field effect transistor-based biosensor for detection of amyloid-beta in human serum. Biosens Bioelectron 2013,50,345-350","journal-title":"Biosens Bioelectron"},{"key":"ref=115","doi-asserted-by":"publisher","first-page":"14303","DOI":"10.1038\/s41598-017-14338-4","volume":"7","author":"Yoo Y.K.","year":"2017","unstructured":"Yoo Y.K.; Yoon D.S.; Kim G.; Kim J.; Han S.I.; Lee J.; Chae M-S.; Lee S-M.; Lee K.H.; Hwang K.S.; Lee J.H.; An enhanced platform to analyse low-affinity amyloid &#x3B2; protein by integration of electrical detection and preconcentrator. Sci Rep 2017,7(1),14303-14303","journal-title":"Sci Rep"},{"key":"ref=116","doi-asserted-by":"publisher","first-page":"323","DOI":"10.1039\/C7AN01683B","volume":"143","author":"Yu Y.","year":"2017","unstructured":"Yu Y.; Wang P.; Zhu X.; Peng Q.; Zhou Y.; Yin T.; Liang Y.; Yin X.; Combined determination of copper ions and &#x3B2;-amyloid peptide by a single ratiometric electrochemical biosensor. Analyst (Lond) 2017,143(1),323-331","journal-title":"Analyst (Lond)"},{"key":"ref=117","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1016\/j.bios.2013.12.036","volume":"56","author":"Rushworth J.V.","year":"2014","unstructured":"Rushworth J.V.; Ahmed A.; Griffiths H.H.; Pollock N.M.; Hooper N.M.; Millner P.A.; A label-free electrical impedimetric biosensor for the specific detection of Alzheimer\u2019s amyloid-beta oligomers. Biosens Bioelectron 2014,56,83-90","journal-title":"Biosens Bioelectron"},{"key":"ref=118","doi-asserted-by":"publisher","first-page":"11743","DOI":"10.1021\/acsami.8b21425","volume":"11","author":"Qin J.","year":"2019","unstructured":"Qin J.; Cho M.; Lee Y.; Ferrocene-encapsulated zn zeolitic imidazole framework (zif-8) for optical and electrochemical sensing of amyloid-&#x3B2; oligomers and for the early diagnosis of alzheimer\u2019s disease. ACS Appl Mater Interfaces 2019,11(12),11743-11748","journal-title":"ACS Appl Mater Interfaces"},{"key":"ref=119","doi-asserted-by":"publisher","first-page":"358","DOI":"10.1016\/j.talanta.2012.02.055","volume":"93","author":"Li H.","year":"2012","unstructured":"Li H.; Cao Y.; Wu X.; Ye Z.; Li G.; Peptide-based electrochemical biosensor for amyloid &#x3B2; 1-42 soluble oligomer assay. Talanta 2012,93,358-363","journal-title":"Talanta"},{"key":"ref=120","doi-asserted-by":"publisher","first-page":"482","DOI":"10.1016\/j.bios.2016.10.077","volume":"92","author":"Wang S.X.","year":"2017","unstructured":"Wang S.X.; Acha D.; Shah A.J.; Hills F.; Roitt I.; Demosthenous A.; Bayford R.H.; Detection of the tau protein in human serum by a sensitive four-electrode electrochemical biosensor. Biosens Bioelectron 2017,92,482-488","journal-title":"Biosens Bioelectron"},{"key":"ref=121","doi-asserted-by":"publisher","first-page":"2823","DOI":"10.1039\/C4AN00204K","volume":"139","author":"Esteves-Villanueva J.O.","year":"2014","unstructured":"Esteves-Villanueva J.O.; Trzeciakiewicz H.; Martic S.; A protein-based electrochemical biosensor for detection of tau protein, a neurodegenerative disease biomarker. Analyst (Lond) 2014,139(11),2823-2831","journal-title":"Analyst (Lond)"},{"key":"ref=122","doi-asserted-by":"publisher","first-page":"513","DOI":"10.1016\/j.bios.2013.10.003","volume":"53","author":"Cheng X.R.","year":"2014","unstructured":"Cheng X.R.; Hau B.Y.; Endo T.; Kerman K.; Au nanoparticle-modified DNA sensor based on simultaneous electrochemical impedance spectroscopy and localized surface plasmon resonance. Biosens Bioelectron 2014,53,513-518","journal-title":"Biosens Bioelectron"},{"key":"ref=123","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1016\/j.electacta.2015.03.210","volume":"172","author":"Congur G.","year":"2015","unstructured":"Congur G.; Eksin E.; Erdem A.;  Impedimetric detection of microrna at graphene oxide modified sensorsElectrochim Acta, 2015,172(Cmplete),20-27","journal-title":"Impedimetric detection of microrna at graphene oxide modified sensorsElectrochim Acta,"},{"key":"ref=124","doi-asserted-by":"publisher","first-page":"55709","DOI":"10.1039\/C7RA09767K","volume":"7","author":"Azimzadeh M.","year":"2017","unstructured":"Azimzadeh M.; Nasirizadeh N.; Rahaie M.; Naderi-Manesh H.; Early detection of Alzheimer\u2019s disease using a biosensor based on electrochemically-reduced graphene oxide and gold nanowires for the quantification of serum microRNA-137. RSC Advances 2017,7(88),55709-55719","journal-title":"RSC Advances"},{"key":"ref=125","doi-asserted-by":"publisher","first-page":"607","DOI":"10.1016\/j.bios.2016.08.104","volume":"87","author":"Moreira F.T.C.","year":"2017","unstructured":"Moreira F.T.C.; Sale M.G.F.; Di Lorenzo M.; Towards timely Alzheimer diagnosis: A self-powered amperometric biosensor for the neurotransmitter acetylcholine. Biosens Bioelectron 2017,87,607-614","journal-title":"Biosens Bioelectron"},{"key":"ref=126","doi-asserted-by":"publisher","first-page":"448","DOI":"10.1016\/j.snb.2018.06.010","volume":"272","author":"Chae M-S.","year":"2018","unstructured":"Chae M-S.; Yoo Y.K.; Kim J.; Kim T.G.; Hwang K.S.; Graphene-based enzyme-modified field-effect transistor biosensor for monitoring drug effects in Alzheimer\u2019s disease treatment. Sens Actuators B Chem 2018,272,448-458","journal-title":"Sens Actuators B Chem"},{"key":"ref=127","doi-asserted-by":"publisher","first-page":"16953","DOI":"10.3791\/55418","volume":"234","author":"Farkhondeh T","year":"2019","unstructured":"Farkhondeh T; Samarghandian S; Pourbagher-Shahri A.M; Sedaghat M; The impact of curcumin and its modified formulations on Alzheimer\u2019s disease. J Cell Physiol 2019,234(10),16953-65","journal-title":"J Cell Physiol"},{"key":"ref=128","doi-asserted-by":"publisher","first-page":"2464","DOI":"10.1016\/j.bios.2010.04.005","volume":"25","author":"Doong R.A.","year":"2010","unstructured":"Doong R.A.; Lee P.S.; Anitha K.; Simultaneous determination of biomarkers for Alzheimer\u2019s disease using sol-gel-derived optical array biosensor. Biosens Bioelectron 2010,25(11),2464-2469","journal-title":"Biosens Bioelectron"},{"key":"ref=129","doi-asserted-by":"publisher","first-page":"959","DOI":"10.1016\/j.bios.2016.09.080","volume":"89","author":"Zhu G.","year":"2017","unstructured":"Zhu G.; Lee H.J.; Electrochemical sandwich-type biosensors for &#x3B1;-1 antitrypsin with carbon nanotubes and alkaline phosphatase labeled antibody-silver nanoparticles. Biosens Bioelectron 2017,89(Pt 2),959-963","journal-title":"Biosens Bioelectron"},{"key":"ref=130","doi-asserted-by":"publisher","DOI":"10.3390\/s18010308","volume":"18","author":"Islam K.","year":"2018","unstructured":"Islam K.; Damiati S.; Sethi J.; Suhail A.; Pan G.; Development of a label-free immunosensor for clustering detection as an Alzheimer\u2019s biomarker. Sensors (Basel) 2018,18(1)","journal-title":"Sensors (Basel)"},{"key":"ref=131","doi-asserted-by":"publisher","first-page":"13325","DOI":"10.1021\/acsnano.9b06571","volume":"13","author":"Brazaca L.C.","year":"2019","unstructured":"Brazaca L.C.; Moreto J.R.; Mart&#xED;n A.; Tehrani F.; Wang J.; Zucolotto V.; Colorimetric paper-based immunosensor for simultaneous determination of fetuin b and clusterin toward early Alzheimer\u2019s diagnosis. ACS Nano 2019,13(11),13325-13332","journal-title":"ACS Nano"}],"container-title":["Current Pharmaceutical Biotechnology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.eurekaselect.com\/article\/download?doi=10.2174\/2666796702666210709122407","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.eurekaselect.com\/194667\/article","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.eurekaselect.com\/article\/download?doi=10.2174\/2666796702666210709122407","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,5,10]],"date-time":"2022-05-10T07:18:48Z","timestamp":1652167128000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.eurekaselect.com\/194667\/article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,4]]},"references-count":131,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2022,4]]}},"alternative-id":["LiveAll1"],"URL":"https:\/\/doi.org\/10.2174\/2666796702666210709122407","relation":{},"ISSN":["1389-2010"],"issn-type":[{"value":"1389-2010","type":"print"}],"subject":[],"published":{"date-parts":[[2022,4]]},"assertion":[{"value":"Peer Reviewed","order":0,"name":"review_status","label":"Review Status","group":{"name":"peer_review_details","label":"Peer Review Details"}},{"value":"Single blind","order":1,"name":"review_process","label":"Review Process","group":{"name":"peer_review_details","label":"Peer Review Details"}},{"value":"Checked with iThenticate","order":0,"name":"screening_status","label":"Screening Status","group":{"name":"plagiarism_screening","label":"Plagiarism Screening"}},{"value":"2020-11-19","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2021-05-30","order":1,"name":"revised","label":"Revised","group":{"name":"publication_history","label":"Publication History"}},{"value":"2021-06-07","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2022-02-03","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}